Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo

WY Kim, M Safran, MRM Buckley, BL Ebert… - The EMBO …, 2006 - embopress.org
WY Kim, M Safran, MRM Buckley, BL Ebert, J Glickman, M Bosenberg, M Regan
The EMBO journal, 2006embopress.org
Many functions have been assigned to the von Hippel‐Lindau tumor suppressor gene
product (pVHL), including targeting the alpha subunits of the heterodimeric transcription
factor HIF (hypoxia‐inducible factor) for destruction. The binding of pVHL to HIFα requires
that HIFα be hydroxylated on one of two prolyl residues. We introduced HIF1α and HIF2α
variants that cannot be hydroxylated on these sites into the ubiquitously expressed ROSA26
locus along with a Lox‐stop‐Lox cassette that renders their expression Cre‐dependent …
Many functions have been assigned to the von Hippel‐Lindau tumor suppressor gene product (pVHL), including targeting the alpha subunits of the heterodimeric transcription factor HIF (hypoxia‐inducible factor) for destruction. The binding of pVHL to HIFα requires that HIFα be hydroxylated on one of two prolyl residues. We introduced HIF1α and HIF2α variants that cannot be hydroxylated on these sites into the ubiquitously expressed ROSA26 locus along with a Lox‐stop‐Lox cassette that renders their expression Cre‐dependent. Expression of the HIF2α variant in the skin and liver induced changes that were highly similar to those seen when pVHL is lost in these organs. Dual expression of the HIF1α and HIF2α variants in liver, however, more closely phenocopied the changes seen after pVHL inactivation than did the HIF2α variant alone. Moreover, gene expression profiling confirmed that the genes regulated by HIF1α and HIF2α in the liver are overlapping but non‐identical. Therefore, the pathological changes caused by pVHL inactivation in skin and liver are due largely to dysregulation of HIF target genes.
embopress.org